or
forgot password

    • cancer clinical trials in wichita, KS

    • Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Associates in Womens Health, PA - North Review

    Trial Locations
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Lung Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    CCOP - Wichita

    Trial Locations
    CCOP - Wichita
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery
    CCOP - Wichita

    Trial Locations
    CCOP - Wichita
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Head and Neck Cancer, Precancerous Condition
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Malignant Mesothelioma
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Breast Cancer
    Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Wichita CCOP

    Trial Locations
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Anaplastic Carcinoma of the Gallbladder, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Cervical Cancer, Endometrial Cancer, Sarcoma
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Cancer Center of Kansas, PA - Wichita

    Trial Locations
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Kidney Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Via Christi Cancer Center at Via Christi Regional Medical Center

    Trial Locations
    Via Christi Cancer Center at Via Christi Regional Medical Center
    Cancer Center of Kansas, PA - Wichita
    Associates in Womens Health, PA - North Review
    Cancer Center of Kansas, PA - Medical Arts Tower
    Breast Cancer
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Associates in Womens Health

    Trial Locations
    Associates in Womens Health
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Cancer Center of Kansas - Main Office
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Wichita CCOP

    Trial Locations
    Wichita CCOP
    Cancer Center of Kansas-Wichita Medical Arts Tower
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma